Increased monocytic CD14+HLADRlow/- myeloid-derived suppressor cells in obesity

Molecular Medicine Reports

Volumn 11, Issue 3, 2015, Pages 2322-2328

  Bao, Yi ^a   Mo, Juanfen ^a   Ruan, Lingjuan ^a   Li, Guo ^a  

^a Jiaxing Second Hospital   (China)

Author keywords

Liver injury; Myeloid derived suppressor cells; Obesity; S100A8 9; T cell receptor

Indexed keywords

CALGRANULIN B; CD14 ANTIGEN; HLA DR ANTIGEN; LIVER ENZYME; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; CELL FUNCTION; CELL SURFACE; CHINESE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; LIVER INJURY; MALE; MONOCYTE; MYELOID DERIVED SUPPRESSOR CELL; OBESITY; SUPPRESSOR CELL; BLOOD; CASE CONTROL STUDY; ECHOGRAPHY; GENETICS; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LIVER FUNCTION TEST; METABOLISM; MONONUCLEAR CELL; PHENOTYPE;

ADULT; ANTIGENS, CD14; CALGRANULIN B; CASE-CONTROL STUDIES; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; LIVER FUNCTION TESTS; MALE; MONOCYTES; MYELOID CELLS; OBESITY; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 84916631696     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2927     Document Type: Article

References (36)

1. Renehan AG, Tyson M, Egger M, Heller RF and Zwahlen M: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578, 2008.
2. Rader DJ: Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120 (Suppl 1): S12-S18, 2007.
3. Leal Vde O and Mafra D: Adipokines in obesity. Clin Chim Acta 419: 87-94, 2013.
4. van der Weerd K, Dik WA, Schrijver B, et al: Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg-and Th2-dominated phenotype. Diabetes 61: 401-408, 2012.
5. de Heredia FP, Gómez-Martinez S and Marcos A: Obesity, inflammation and the immune system. Proc Nutr Soc 71: 332-338, 2012.
6. Wagner NM, Brandhorst G, Czepluch F, et al: Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring) 21: 461-468, 2013.
7. Lindau D, Gielen P, Kroesen M, Wesseling P and Adema GJ: The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 138: 105-115, 2013.
8. Umansky V and Sevko A. Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation. Cancer Immunol Immunother 61: 275-282, 2012.
9. Irving BA, Chan AC and Weiss A: Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J Exp Med 177: 1093-1103, 1993.
10. Irving BA and Weiss A: The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64: 891-901, 1991.
11. Srivastava MK, Andersson A, Zhu L, et al: Myeloid suppressor cells and immune modulation in lung cancer. Immunotherapy 4: 291-304, 2012.
12. Zhao F, Hoechst B, Duffy A, et al: S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology 136: 176-183, 2012.
13. Schouppe E, Van Overmeire E, Laoui D et al: Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells. Immunobiology 218: 1385-1391, 2013.
14. Kono K, Ressing ME, Brandt RM, et al: Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 2: 1825-1828, 1996.
15. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association: Diagnostic criteria of nonalcoholic fatty liver disease. Zhoonghua Gan Zang Bing Za Zhi 11: 71, 2003 (In Chinese).
16. Kusmartsev S, Su Z, Heiser A, et al: Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res 14: 8270-8278, 2008.
17. Ozao-Choy J, Ma G, Kao J, et al: The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res 69: 2514-2522, 2009.
18. Wang L, Chang EW, Wong SC, et al: Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 190: 794-804, 2013.
19. Filipazzi P, Valenti R, Huber V, et al: Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol 25: 2546-2553, 2007.
20. Gebhardt C, Németh J, Angel P and Hess J: S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72: 1622-1631, 2006.
21. Foell D, Wittkowski H, Ren Z, et al: Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol 216: 183-192, 2008.
22. Auffray C, Sieweke MH and Geissmann F: Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27: 669-692, 2009.
23. Hansmann L, Groeger S, von Wulffen W, Bein G and Hackstein H: Human monocytes represent a competitive source of interferon-alpha in peripheral blood. Clin Immunol 127: 252-264, 2008.
24. Lin Y, Gustafson MP, Bulur PA et al: Immunosuppressive CD14+HLA-DR(low)/-monocytes in B-cell non-Hodgkin lymphoma. Blood 117: 872-881, 2011.
25. Najjar YG and Finke JH: Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Front Oncol 3: 49, 2013.
26. Monneret G, Lepape A, Voirin N, et al: Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32: 1175-1183, 2006.
27. Mentula P, Kylänpää-Bäck ML, Kemppainen E, et al: Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Sci (Lond) 105: 409-417, 2003.
28. Antoniades CG, Berry PA, Davies ET, et al: Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44: 34-43, 2006.
29. Zimmermann HW, Trautwein C and Tacke F: Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 3: 56, 2012.
30. Trayhurn P and Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347-355, 2004.
31. Trayhurn P, Bing C and Wood IS: Adipose tissue and adipokines ? energy regulation from the human perspective. J Nutr 136 (Suppl 7): 1935S-1939S, 2006.
32. Rahimi RS and Landaverde C: Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. Nutr Clin Pract 28: 40-51, 2013.
33. Höchst B, Schildberg FA, Sauerborn P, et al: Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J Hepatol 59: 528-535, 2013.
34. Baniyash M: TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol 4: 675-687, 2004.
35. Whiteside TL: Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer? Cancer Immunol Immunother 53: 865-878, 2004.
36. Sinha P, Okoro C, Foell D, et al: Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181: 4666-4675, 2008.